Close

Dr Katherine Horton

Assistant Professor - TB Modelling Group

London School of Hygiene & Tropical Medicine
Keppel St
London
WC1E 7HT
United Kingdom

Katherine Horton is an infectious disease epidemiologist with experience in research, surveillance, and rapid response, as well as pandemic preparedness and global health security, in settings across Africa, the Eastern Mediterranean, South East Asia, and the Western Pacific. She holds a PhD in Epidemiology and Mathematical Modelling from LSHTM, an MPH in Global Epidemiology from Emory University, and a BSc in Mathematical Sciences from Clemson University.

Affiliations

Department of Infectious Disease Epidemiology and Dynamics
Faculty of Epidemiology and Population Health

Centres

TB Centre

Teaching

Katherine is a co-organiser for the distance-learning Epidemiology of Infectious Diseases module and a facilitator for Social Epidemiology. She  also supervises PhD, DrPH, and MSc students.

Research

As an epidemiologist and mathematical modeller, Katherine aims to generate quantitative evidence to inform tuberculosis (TB) policy and practice. Her current research interests include gender and other structural determinants, strategies to interrupt transmission, systematic screening, the spectrum of disease, and vaccine trial design.

 

Prior to joining LSHTM, Katherine managed research and surveillance protocols on acute respiratory infections, sexually transmitted infections, and vector-borne and zoonotic infections with the U.S. Centers for Disease Control and Prevention Global Disease Detection Centre in Egypt, and she supported HIV voluntary counselling and testing, cohort studies, and clinical trials with Emory University in Rwanda and Zambia. She has also consulted for the World Health Organization Regional Office for the Western Pacific on pandemic preparedness and rapid response and for the World Health Organization Global TB Programme.

Disease and Health Conditions
Tuberculosis
Influenza
HIV/AIDS
Zoonoses
Respiratory diseases
Country
Malawi
Nigeria
Kenya
Uganda
Vietnam
Egypt
Djibouti
Rwanda
Zambia
Brazil
South Africa
India
Region
Middle East & North Africa (all income levels)
Sub-Saharan Africa (all income levels)

Selected Publications

The potential impact of reduced international donor funding on the household economic burden of tuberculosis in low- and middle-income countries
Portnoy, A; CLARK, R; Jit, M; MCQUAID, F; Richards, A; Bakker, R; Sumner, T; Prŷs-Jones, T; HOUBEN, RM G J; WHITE, R; HORTON, K; Menzies, N;
2025
medRxiv
The potential impact of reductions in international donor funding on tuberculosis in low-income and middle-income countries: a modelling study.
CLARK, RA; MCQUAID, CF; Richards, AS; Bakker, R; SUMNER, T; Prŷs-Jones, TO; HOUBEN, RM G J; WHITE, RG; HORTON, KC;
2025
The Lancet Global health
Evidence required to evaluate the use of bacteriologically confirmed asymptomatic tuberculosis disease as a primary endpoint in prevention of tuberculosis disease vaccine licensure trials.
WHITE, RG; Churchyard, GJ; HORTON, KC; Fiore-Gartland, A; Behr, MA; CLARK, RA; Cobelens, F; Ernst, JD; Esmail, H; Garcia-Basteiro, AL; Hadinegoro, SR; Hanekom, WA; Hatherill, M; Hill, PC; Muloiwa, R; Pelzer, PT; Rangaka, L; Rees, H; Schrager, L; Stanley, M; Tufet, M; Wong, EB; HOUBEN, RM G J;
2025
The Lancet. Respiratory medicine
The potential impact of reductions in international donor funding on tuberculosis in low- and middle-income countries.
CLARK, RA; MCQUAID, CF; RICHARDS, AS; Bakker, R; SUMNER, T; Prŷs-Jones, T; Houben, RM G J; WHITE, RG; HORTON, KC;
2025
medRxiv
Perceived Gender Equitable Norms and Previous Tuberculosis Testing in Malawi: A Secondary Analysis of a Cluster-based Prevalence Survey
Di Giacomo, E; NIGHTINGALE, E; MacPherson, P; Feasey, HR A; Soko, R; Phiri, V; Corbett, E; HORTON, K;
2025
medRxiv
Population level impact of increasing tuberculosis treatment coverage and addressing determinants of risk in men: a modelling study in Kenya, Malawi, Nigeria, and Uganda
RICHARDS, A; Phiri, M; Nidoi, J; Chakaya, J; MacPherson, P; Kirenga, B; Bimba, J; Ugwu, C; Pola, R; Squire, B; HORTON, K;
2025
medRxiv
Estimating the Impact of Tuberculosis Pathways on Transmission-What Is the Gap Left by Passive Case Finding?
HORTON, KC; McCaffrey, T; RICHARDS, AS; SCHWALB, A; HOUBEN, RM G J;
2024
The Journal of infectious diseases
Reevaluating progression and pathways following Mycobacterium tuberculosis infection within the spectrum of tuberculosis.
HORTON, KC; RICHARDS, AS; EMERY, JC; Esmail, H; HOUBEN, RM G J;
2023
Proceedings of the National Academy of Sciences of the United States of America
Missing men with tuberculosis: the need to address structural influences and implement targeted and multidimensional interventions.
Chikovore, J; Pai, M; HORTON, KC; Daftary, A; Kumwenda, MK; Hart, G; CORBETT, EL;
2020
BMJ Global Health
See more information